## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence as presented in the abstract; no access to full manuscript, figures, tables, or supplementary information
- **Shared manuscript claim summary** The authors report a multiscale computational study of covalent organic pyrgos[n]cages (PC[n], n = 1-4) as potential dual modulators of VEGFR-2 D2-D3 domain (wild type and mutant) and DNA (duplex and fork) structures. They claim preferential localization of PC[2-4] in the VEGFR-2 D23 interdomain cleft with multivalent interactions, structurally stable DNA groove-associated binding, and favorable binding enthalpy estimates for PC[4] with VEGFR-2 D23, mutant VEGFR-2 D23, and duplex DNA, and for PC[2] with fork DNA.
- **Visible evidence base** Abstract text only; no methodological details, simulation parameters, force fields, system setup, convergence criteria, or numerical data beyond binding enthalpy estimates
- **Missing materials affecting confidence** Full manuscript, methods section, simulation protocols, force field parameters, system size and equilibration details, error analysis methodology, structural figures, trajectory analyses, convergence assessments, and any experimental validation

## Reviewer
- **Overall assessment** The abstract presents a potentially interesting computational exploration of organic cages as dual protein-DNA binders, which could be of interest to the computational chemistry and drug design communities. However, the current evidence base is insufficient to evaluate the technical soundness of the simulations or the robustness of the reported binding enthalpy estimates. The claims of dual modulation are plausible but not established from the abstract alone. The lack of methodological detail and the absence of any comparative benchmarking or experimental context limit the ability to assess the significance of the findings.
- **Who would be interested in the results, and why** Computational chemists and materials scientists working on porous organic cages and host-guest chemistry may find the design concept interesting. Researchers in computational drug discovery targeting protein-protein or protein-DNA interfaces could be interested in the dual-targeting approach. However, the narrow scope of the study (one receptor, one DNA type, no experimental validation) may limit broader appeal.
- **Major strengths** The concept of using purely covalent organic cages with electronically adaptive pi-stacked systems as dual modulators of protein and DNA interfaces is novel and potentially impactful. The inclusion of both wild-type and mutant VEGFR-2 D23 variants, as well as duplex and fork DNA, suggests a systematic exploration of target diversity. The reported binding enthalpy estimates provide quantitative comparisons across systems.
- **Major Concerns** 
  - R1-M1
  - R1-M2
  - R1-M3
- **Minor Comments** 
  - R1-m1
  - R1-m2
  - R1-m3
  - R1-m4
- **Technical failings that need to be addressed before the case is established** R1-M1 (methodological transparency), R1-M2 (validation and benchmarking), R1-M3 (statistical robustness)
- **Assessment against Nature-style criteria** Originality is moderate to high given the novel application of organic cages to dual protein-DNA targeting. Scientific importance is currently unclear because the abstract does not demonstrate functional significance beyond binding enthalpy estimates, and no experimental or in vivo context is provided. Interdisciplinary readership is limited by the highly specialized computational focus without broader biological or clinical framing. Technical soundness cannot be assessed from the abstract alone due to missing methodological details. Readability for nonspecialists is acceptable but the abstract assumes familiarity with computational binding free energy methods and organic cage chemistry.
- **Recommendation posture** Currently not established from the provided evidence. The concept is interesting but the abstract alone does not provide sufficient methodological detail, validation, or statistical robustness to support the core claims. A revised manuscript with full methods, convergence analyses, and benchmarking would be needed to assess whether the case can be established.

### Major Concerns

- **Concern ID** R1-M1
- **Severity** Major
- **Blocking** Yes
- **Axis** Technical soundness
- **Claim pointer** The authors claim that molecular dynamics simulations and electronic structure analyses indicate preferential localization of PC[2-4] within the VEGFR-2 D23 interdomain cleft and structurally stable DNA groove-associated binding.
- **Evidence pointer** Abstract only; location not provided
- **Concern** The abstract provides no information on the simulation methodology, including force field parameters, water model, ionic conditions, simulation length, temperature and pressure coupling, equilibration protocol, or the electronic structure method used. Without these details, the reliability of the reported interactions and binding modes cannot be evaluated.
- **Why it matters** Binding mode predictions from molecular dynamics are highly sensitive to force field choice and sampling length. The absence of methodological transparency prevents any assessment of whether the observed interactions are artifacts of the simulation setup or genuine physical phenomena.
- **Resolution test** Provide a detailed methods section describing force field parameters, simulation protocols, system sizes, equilibration and production lengths, and electronic structure methods. Include convergence analyses (e.g., root-mean-square deviation over time, block averaging) to demonstrate that the reported binding modes are stable and reproducible.

- **Concern ID** R1-M2
- **Severity** Major
- **Blocking** Yes
- **Axis** Validation and benchmarking
- **Claim pointer** The authors claim that PC[4] exhibits the most favorable binding enthalpy estimates for VEGFR-2 D23 (-48.3 +/- 3.5 kcal mol(-1)), mutant M-VEGFR-2 D23 (-24.3 +/- 5.8 kcal mol(-1)), and duplex DNA (-44.8 +/- 3.8 kcal mol(-1)), and PC[2] shows favorable interaction with fork DNA (-46.3 +/- 4.5 kcal mol(-1)).
- **Evidence pointer** Abstract only; location not provided
- **Concern** The binding enthalpy estimates are presented without any benchmarking against known binders, experimental data, or alternative computational methods. The abstract does not indicate whether these values are absolute binding free energies, enthalpy-only estimates, or relative rankings. No comparison to a positive or negative control is provided.
- **Why it matters** Without benchmarking, the reported values are difficult to interpret. A value of -48.3 kcal mol(-1) for a protein-ligand interaction is unusually large and may indicate overestimation or methodological artifacts. The lack of context makes it impossible to judge whether these estimates are physically reasonable or merely computational outputs.
- **Resolution test** Benchmark the computational protocol against a known VEGFR-2 binder or a structurally characterized protein-DNA complex. Compare the reported enthalpy estimates with experimental binding affinities where available. Provide error estimates from multiple independent simulations and discuss the physical plausibility of the magnitudes.

- **Concern ID** R1-M3
- **Severity** Major
- **Blocking** Yes
- **Axis** Statistical robustness
- **Claim pointer** The authors report binding enthalpy estimates with standard deviations (e.g., -48.3 +/- 3.5 kcal mol(-1)) and claim that PC[4] exhibits the most favorable binding among the studied systems.
- **Evidence pointer** Abstract only; location not provided
- **Concern** The abstract does not specify how many independent simulations were performed, how the standard deviations were calculated, or whether the differences between systems (e.g., PC[4] vs. PC[3] for VEGFR-2 D23) are statistically significant. The reported uncertainties may reflect only a single trajectory or insufficient sampling.
- **Why it matters** The claim that PC[4] is the most favorable binder depends on the statistical significance of the differences between systems. Without this information, the ranking could be due to noise rather than genuine physical differences.
- **Resolution test** Report the number of independent simulations, the method for calculating uncertainties (e.g., block averaging, bootstrapping), and statistical tests (e.g., t-tests or analysis of variance) comparing binding estimates across systems. Show that the differences between PC[4] and other cages are significant beyond the reported uncertainties.

### Minor Comments

- **Concern ID** R1-m1
- **Severity** Minor
- **Axis** Clarity of terminology
- **Affected element** Interaction terminology
- **Evidence pointer** Abstract text
- **Issue** The abstract uses nonstandard notation "picdots, three dots, centeredpi stacking" and "picdots, three dots, centeredH interactions" which is not conventional in the literature. This may confuse readers unfamiliar with the notation.
- **Required correction** Replace with standard terminology such as "pi-pi stacking" and "C-H...pi interactions" or provide a clear definition of the notation upon first use.

- **Concern ID** R1-m2
- **Severity** Minor
- **Axis** Completeness of target rationale
- **Affected element** Biological relevance
- **Evidence pointer** Abstract text
- **Issue** The abstract states that VEGFR-2 D23 signaling plays a central role in tumor vascularization but does not explain why dual modulation of VEGFR-2 and DNA is therapeutically relevant or how the two targets are functionally linked.
- **Required correction** Add a sentence explaining the potential therapeutic rationale for dual targeting, such as synergistic effects on angiogenesis and tumor cell proliferation, or a specific disease context.

- **Concern ID** R1-m3
- **Severity** Minor
- **Axis** Scope of claims
- **Affected element** "Potential to modulate"
- **Evidence pointer** Abstract text
- **Issue** The final claim that the findings "highlight its potential to modulate the VEGFR-2 D23 domain and DNA binding" is vague and does not specify the direction or magnitude of modulation (e.g., inhibition, stabilization, or allosteric effects).
- **Required correction** Clarify whether the cages are proposed as inhibitors, stabilizers, or allosteric modulators, and specify the expected functional outcome based on the computational evidence.

- **Concern ID** R1-m4
- **Severity** Minor
- **Axis** Reporting of uncertainties
- **Affected element** Binding enthalpy values
- **Evidence pointer** Abstract text
- **Issue** The binding enthalpy estimates are reported with uncertainties but no indication of the number of significant figures or the method of error propagation.
- **Required correction** Specify the number of independent measurements and the method used to calculate the reported uncertainties.

## Risk / unsupported claims
- The claim that PC[2-4] frameworks "preferentially localize" within the VEGFR-2 D23 interdomain cleft is unsupported without details on the simulation sampling and free energy calculations.
- The claim that the interaction pattern "suggests potential steric interference with VEGF binding" is speculative and not directly tested in the abstract.
- The claim that binding preserves "overall receptor structural stability" is unsupported without structural analyses (e.g., root-mean-square fluctuation or secondary structure analyses).
- The claim that DNA binding is "structurally stable" is unsupported without trajectory analyses or binding free energy calculations.
- The relative ranking of PC[4] as the most favorable binder is not statistically substantiated.
- The functional significance of the reported binding enthalpy estimates for therapeutic modulation is not established.